Neoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferation.
Severson TM, Nevedomskaya E, Peeters J, Kuilman T, Krijgsman O, van Rossum A, Droog M, Kim Y, Koornstra R, Beumer I, Glas AM, Peeper D, Wesseling J, Simon IM, Wessels L, Linn SC, Zwart W.
Severson TM, et al. Among authors: wessels l.
Oncotarget. 2016 Jun 7;7(23):33901-18. doi: 10.18632/oncotarget.8983.
Oncotarget. 2016.
PMID: 27129152
Free PMC article.
Clinical Trial.